EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Legumain in cardiovascular diseases

Lei Zhou, Jianqiang Wu, Zairong Wei, Yuehong Zheng

Experimental Biology and Medicine · 2024

DOI: 10.3389/ebm.2024.10121 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Experimental Biology and Medicine, 2024. Verfasst von Lei Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Burns and Plastic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, China. Hauptthemen laut MEDLINE: Cysteine Endopeptidases, Cardiovascular Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular diseases (CVDs) are the leading cause of death worldwide, having become a global public health problem, so the pathophysiological mechanisms and therapeutic strategies of CVDs need further study. Legumain is a powerful enzyme that is widely distributed in mammals and plays an important role in a variety of biological processes. Recent research suggests that legumain is associated with the occurrence and progression of CVDs. In this review, we provide a comprehensive overview of legumain in the pathogenesis of CVDs. The role of legumain in CVDs, such as carotid atherosclerosis, pulmonary hypertension, coronary artery disease, peripheral arterial disease, aortic aneurysms and dissection, is discussed. The potential applications of legumain as a biomarker of these diseases are also explored. By understanding the role of legumain in the pathogenesis of CVDs, we aim to support new therapeutic strategies to prevent or treat these diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cysteine EndopeptidasesCardiovascular DiseasesHumansAnimalsBiomarkersAsparaginyl Endopeptidase

Stichwörter der Autor:innen

aortic diseaseatherosclerosiscardiovascular diseasecoronary artery diseaselegumain

Substanzen

Cysteine EndopeptidasesBiomarkersAsparaginyl Endopeptidase

Autor:innen und Institutionen

  • Department of Burns and Plastic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
  • Department of Vascular Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Institute of Clinical Medicine, National Science and Technology Key Infrastructure on Translational Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Acad…

Zitieren

APA

Zhou, L., Wu, J., Wei, Z., & Zheng, Y. (2024). Legumain in cardiovascular diseases. Experimental Biology and Medicine. https://doi.org/10.3389/ebm.2024.10121

Vancouver

Zhou L, Wu J, Wei Z, Zheng Y. Legumain in cardiovascular diseases. Experimental Biology and Medicine. 2024. doi:10.3389/ebm.2024.10121

BibTeX
@article{Zhou2024,
  author = {Zhou, Lei and Wu, Jianqiang and Wei, Zairong and Zheng, Yuehong},
  title = {Legumain in cardiovascular diseases},
  journal = {Experimental Biology and Medicine},
  year = {2024},
  doi = {10.3389/ebm.2024.10121}
}
Kostenlos starten →